|
1
|
Jiang P and Mizushima N: Autophagy and
human diseases. Cell Res. 24:69–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Choi AM, Ryter SW and Levine B: Autophagy
in human health and disease. N Engl J Med. 368:651–662. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Janku F, McConkey DJ, Hong DS and Kurzrock
R: Autophagy as a target for anticancer therapy. Nat Rev Clin
Oncol. 8:528–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Santana-Codina N, Mancias JD and Kimmelman
AC: The Role of Autophagy in Cancer. Ann Rev Cancer Biol. 1:19–39.
2017. View Article : Google Scholar
|
|
5
|
Mizushima N and Komatsu M: Autophagy:
Renovation of cells and tissues. Cell. 147:728–741. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Degenhardt K, Mathew R, Beaudoin B, Bray
K, Anderson D, Chen G, Mukherjee C, Shi Y, Gélinas C, Fan Y, et al:
Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell. 10:51–64. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lum JJ, Bauer DE, Kong M, Harris MH, Li C,
Lindsten T and Thompson CB: Growth factor regulation of autophagy
and cell survival in the absence of apoptosis. Cell. 120:237–248.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jin S and White E: Role of autophagy in
cancer: Management of metabolic stress. Autophagy. 3:28–31. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Emanuele S, Lauricella M and Tesoriere G:
Histone deacetylase inhibitors: Apoptotic effects and clinical
implications (Review). Int J Oncol. 33:637–646. 2008.PubMed/NCBI
|
|
10
|
Zhang J, Ng S, Wang J, Zhou J, Tan SH,
Yang N, Lin Q, Xia D and Shen HM: Histone deacetylase inhibitors
induce autophagy through FOXO1-dependent pathways. Autophagy.
11:629–642. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim HJ and Bae SC: Histone deacetylase
inhibitors: Molecular mechanisms of action and clinical trials as
anti-cancer drugs. Am J Transl Res. 3:166–179. 2011.PubMed/NCBI
|
|
12
|
Hoshikawa Y, Kwon HJ, Yoshida M,
Horinouchi S and Beppu T: Trichostatin A induces morphological
changes and gelsolin expression by inhibiting histone deacetylase
in human carcinoma cell lines. Exp Cell Res. 214:189–197. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu YL, Yang PM, Shun CT, Wu MS, Weng JR
and Chen CC: Autophagy potentiates the anti-cancer effects of the
histone deacetylase inhibitors in hepatocellular carcinoma.
Autophagy. 6:1057–1065. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gammoh N, Lam D, Puente C, Ganley I, Marks
PA and Jiang X: Role of autophagy in histone deacetylase
inhibitor-induced apoptotic and nonapoptotic cell death. Proc Natl
Acad Sci USA. 109:pp. 6561–6565. 2012; View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chiao MT, Cheng WY, Yang YC, Shen CC and
Ko JL: Suberoylanilide hydroxamic acid (SAHA) causes tumor growth
slowdown and triggers autophagy in glioblastoma stem cells.
Autophagy. 9:1509–1526. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eijkelenboom A and Burgering BM: FOXOs:
Signalling integrators for homeostasis maintenance. Nat Rev Mol
Cell Biol. 14:83–97. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Burgering BM: A brief introduction to
FOXOlogy. Oncogene. 27:2258–2262. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Michaelis M, Suhan T, Michaelis UR, Beek
K, Rothweiler F, Tausch L, Werz O, Eikel D, Zörnig M, Nau H, et al:
Valproic acid induces extracellular signal-regulated kinase 1/2
activation and inhibits apoptosis in endothelial cells. Cell Death
Differ. 13:446–453. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jazirehi AR: Regulation of
apoptosis-associated genes by histone deacetylase inhibitors:
Implications in cancer therapy. Anticancer Drugs. 21:805–813. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park H, Lee YJ, Kim TH, Lee J, Yoon S,
Choi WS, Myung CS and Kim HS: Effects of trichostatin A, a histone
deacetylase inhibitor, on the regulation of apoptosis in
H-ras-transformed breast epithelial cells. Int J Mol Med.
22:605–611. 2008.PubMed/NCBI
|
|
21
|
Yang Y, Zhao Y, Liao W, Yang J, Wu L,
Zheng Z, Yu Y, Zhou W, Li L, Feng J, et al: Acetylation of FoxO1
activates Bim expression to induce apoptosis in response to histone
deacetylase inhibitor depsipeptide treatment. Neoplasia.
11:313–324. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Del Bufalo D, Desideri M, De Luca T, Di
Martile M, Gabellini C, Monica V, Busso S, Eramo A, De Maria R,
Milella M and Trisciuoglio D: Histone deacetylase inhibition
synergistically enhances pemetrexed cytotoxicity through induction
of apoptosis and autophagy in non-small cell lung cancer. Mol
Cancer. 13:2302014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang PM and Chen CC: Life or death?
Autophagy in anticancer therapies with statins and histone
deacetylase inhibitors. Autophagy. 7:107–108. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hrzenjak A, Kremser ML, Strohmeier B,
Moinfar F, Zatloukal K and Denk H: SAHA induces
caspase-independent, autophagic cell death of endometrial stromal
sarcoma cells by influencing the mTOR pathway. J Pathol.
216:495–504. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Carew JS, Medina EC, Esquivel JA II,
Mahalingam D, Swords R, Kelly K, Zhang H, Huang P, Mita AC, Mita
MM, et al: Autophagy inhibition enhances vorinostat-induced
apoptosis via ubiquitinated protein accumulation. J Cell Mol Med.
14:2448–2459. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lopez G, Torres K, Liu J, Hernandez B,
Young E, Belousov R, Bolshakov S, Lazar AJ, Slopis JM, McCutcheon
IE, et al: Autophagic survival in resistance to histone deacetylase
inhibitors: Novel strategies to treat malignant peripheral nerve
sheath tumors. Cancer Res. 71:185–196. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ungerstedt JS, Sowa Y, Xu WS, Shao Y,
Dokmanovic M, Perez G, Ngo L, Holmgren A, Jiang X and Marks PA:
Role of thioredoxin in the response of normal and transformed cells
to histone deacetylase inhibitors. Proc Natl Acad Sci USA. 102:pp.
673–678. 2005; View Article : Google Scholar : PubMed/NCBI
|
